Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

The world is winning the war on cancer

Mint Mumbai

|

July 19, 2025

In 1971 Richard Nixon, then America's president, announced a "war on cancer".

The world is winning the war on cancer

Just two years earlier the Apollo programme had combined big science and big government to put astronauts on the moon, so hopes were high. Some optimistic doctors talked of a cure for cancer within a few years.

They were wrong. Today every adult has had cancer, knows someone who has, or both. Half of men and a third of women in rich countries can expect to suffer from it at some point in their lives. In America, where it is the second-most-common cause of death, just behind heart disease, it kills around 600,000 people a year. Worldwide, it is responsible for about one in six of all deaths. If your criterion for success was a cure within a decade or even two or three or four-then you might conclude that the war on cancer has been lost.

In fact, things are better than many realize. The progress is plain from the data and there is every reason to think it will continue. Cancer is related to age. If you strip out longer lifespans, it becomes clear that in the rich world the early 1990s were an inflection point. Since then, the age-adjusted death rate has been falling, slowly but steadily, year after year. In America the rate is now about a third lower than in the 1990s. The trend is similar in other developed countries.

What some scientists hoped would be a blitzkrieg has turned out to be a steady but successful war of attrition. Some victories have been spectacular. Childhood leukaemia used to be virtually a death sentence; now it has a five-year survival rate above 90%. Yet because cancer is not one illness, but a whole category, much of the progress has come not from big breakthroughs, but thousands of smaller advances in screening, surgery and drugs.

FLERE HISTORIER FRA Mint Mumbai

Mint Mumbai

Europe bets on $25 bn space budget amid defence hike

Europe’s equivalent of NASA is seeking €22 billion ($25.

time to read

1 min

November 27, 2025

Mint Mumbai

Mint Mumbai

China’s ‘McNuggetization’: It’s beneficial for the environment

A wide-scope dietary shift in China is doing the planet a good turn

time to read

3 mins

November 27, 2025

Mint Mumbai

Flexi-cap funds in focus as smids falter

A silent pivot

time to read

3 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

Labour codes: Focus on empathy and not just efficiency

The consolidation of 29 archaic labour laws into four comprehensive new codes—on wages, social security, industrial relations and occupational safety—is among the most significant structural reforms undertaken by India in the post-liberalization era.

time to read

3 mins

November 27, 2025

Mint Mumbai

These firms will sell shovels during semaglutide gold rush

Weight-loss drug semaglutide, also used to treat type-2 diabetes, will face its next big turning point in early 2026, when patents held by Novo Nordisk expire in India.

time to read

2 mins

November 27, 2025

Mint Mumbai

HC to hear Apple's plea on fine in Dec

Apple is challenging the new penalty math formula in India's competition law.

time to read

1 min

November 27, 2025

Mint Mumbai

Climate crisis: Innovation works, compression doesn't

After weeks of hot air, the UN’s CoP summit limped to an end in Brazil's Amazonian hub of Belém over the weekend, with a ‘deal’ that delivers nothing measurable for the climate, while wasting political capital and much effort on pledges.

time to read

3 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

MO Alternates launches its maiden private credit fund

The %3,000 crore fund has drawn capital from family offices, ultra-HNIs and institutions

time to read

3 mins

November 27, 2025

Mint Mumbai

Kharif grain production likely to rise to 173 mt

India's kharif foodgrain output is expected to rise to 173.

time to read

1 min

November 27, 2025

Mint Mumbai

IL&FS group repays ₹48,463 cr loan

Debt-ridden IL&FS group has repaid ₹48,463 crore to its creditors as of September 2025, out of the total ₹61,000 crore debt resolution target, as per the latest status report filed before insolvency appellate tribunal NCLAT.

time to read

1 min

November 27, 2025

Listen

Translate

Share

-
+

Change font size